Nan Fung Group Holdings »

Athira Pharma shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Athira Pharma (ATHA) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $364k 180k 2.02
2023-06-30 $35k 12k 2.95

More positions owned by Nan Fung Group Holdings

Karuna Therapeutics Ord
Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Seagen
Oculis Holding Ordinary Shares (OCS)
Somalogic Class A Com
Exscientia Ads (EXAI)
Xenon Pharmaceuticals (XENE)
Merus N V (MRUS)
Replimune Group (REPL)
Kalvista Pharmaceuticals (KALV)
Beigene Sponsored Adr (BGNE)
Alpine Immune Sciences (ALPN)
Incyte Corporation (INCY)
Geron Corporation (GERN)

View all positions for Nan Fung Group Holdings

Top funds holding Athira Pharma

Perceptive Advisors
Baker Bros. Advisors
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
BML Capital Management
Millennium Management
Pathstone Holdings
Citadel Advisors
Dimensional Fund Advisors
Two Sigma Investments
Two Sigma Advisers
Jacobs Levy Equity Management
GSA Capital Partners

View all funds holding Athira Pharma